Next Article in Journal
Environmentally Relevant Concentrations of Triphenyl Phosphate (TPhP) Impact Development in Zebrafish
Next Article in Special Issue
Inhibitory Impact of Prenatal Exposure to Nano-Polystyrene Particles on the MAP2K6/p38 MAPK Axis Inducing Embryonic Developmental Abnormalities in Mice
Previous Article in Journal
Hair Mercury Levels in Pregnant Women: Fish Consumption as a Determinant of Exposure
Previous Article in Special Issue
Restricted-Access Media Column Switching Online Solid-Phase Extraction UHPLC–MS/MS for the Determination of Seven Type B Trichothecenes in Whole-Grain Preprocessed Foods and Human Exposure Risk Assessment
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Toxics
Volume 12
Issue 5
10.3390/toxics12050367
toxics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Titanium Dioxide Nanoparticles Induce Maternal Preeclampsia-like Syndrome and Adverse Birth Outcomes via Disrupting Placental Function in SD Rats

by
Haixin Li
1,†,
Dandan Miao
2,†,
Haiting Hu
1,
Pingping Xue
1,
Kun Zhou
3,4,5,* and
Zhilei Mao
1,3,4,*
1
Changzhou Maternity and Child Health Care Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou 213003, China
2
Huai’an Center for Disease Control and Prevention, Huai’an 223001, China
3
State Key Laboratory of Reproductive Medicine, Center for Global Health, Nanjing Medical University, Nanjing 211100, China
4
Key Laboratory of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211100, China
5
Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Toxics 2024, 12(5), 367; https://doi.org/10.3390/toxics12050367
Submission received: 21 April 2024 / Revised: 8 May 2024 / Accepted: 13 May 2024 / Published: 16 May 2024
(This article belongs to the Special Issue State-of-the-Art Environmental Chemicals Exposomics and Metabolomics)
Browse Figures
Versions Notes

Abstract

:
The escalating utilization of titanium dioxide nanoparticles (TiO2 NPs) in everyday products has sparked concerns regarding their potential hazards to pregnant females and their offspring. To address these concerns and shed light on their undetermined adverse effects and mechanisms, we established a pregnant rat model to investigate the impacts of TiO2 NPs on both maternal and offspring health and to explore the underlying mechanisms of those impacts. Pregnant rats were orally administered TiO2 NPs at a dose of 5 mg/kg body weight per day from GD5 to GD18 during pregnancy. Maternal body weight, organ weight, and birth outcomes were monitored and recorded. Maternal pathological changes were examined by HE staining and TEM observation. Maternal blood pressure was assessed using a non-invasive blood analyzer, and the urinary protein level was determined using spot urine samples. Our findings revealed that TiO2 NPs triggered various pathological alterations in maternal liver, kidney, and spleen, and induced maternal preeclampsia-like syndrome, as well as leading to growth restriction in the offspring. Further examination unveiled that TiO2 NPs hindered trophoblastic cell invasion into the endometrium via the promotion of autophagy. Consistent hypertension and proteinuria resulted from the destroyed the kidney GBM. In total, an exposure to TiO2 NPs during pregnancy might increase the risk of human preeclampsia through increased maternal arterial pressure and urinary albumin levels, as well as causing fetal growth restriction in the offspring.

1. Introduction

Titanium dioxide nanoparticles (TiO2 NPs) were among the first nanoparticles produced and used worldwide, mainly finding applications in sunscreen, paint, ink, and as a food additive [1,2,3]. TiO2 NPs are present in various environmental media, with the primary route of human exposure being through the digestive tract via food [4]. Pregnant women, therefore, cannot avoid exposure to them. Studies have shown that fetuses are more sensitive to toxins than adults, and prenatal exposure can lead to developmental toxicity in offspring [5]. To date, limited human epidemiological evidence regarding the hazards of TiO2 NPs to pregnant women and birth outcomes has been reported. Existing studies about the toxicity of TiO2 NPs mainly focus on animal models [6,7], making related studies urgently necessary.
Previous research has indicated that TiO2 NPs can reach and accumulate in the placenta, leading to a smaller feto-placental unit [8]. They can even penetrate the placental barrier, reach fetal brains, and ultimately affect the offspring’s neurodevelopment [9]. These findings underscore that the placenta is one of the target organs of TiO2 NPs. The placenta plays a vital role in embryo development, facilitating substrate exchange, hormone secretion, and immune defense [10]. Trophoblastic cells are a type of cell that plays a crucial role in the development of the placenta during pregnancy, and their migration and invasion ability are crucial for placental development [11]. The impaired function of trophoblastic cells can result in inadequate infiltration of the placenta into the endometrium and a failure to complete spiral artery (SA) remodeling. Placental dysfunction can lead to abortion, fetal growth restriction, intrauterine anoxia, and even fetal death [12,13,14]. Other pregnancy-related diseases, such as preeclampsia and uteroplacental apoplexy, have also been linked to placental dysfunction [15]. However, whether TiO2 NPs affect placental development and induce maternal pregnancy diseases and adverse birth outcomes remains unclear and requires further study.
The placental development and trophoblastic cell invasion pattern in rats closely resemble those in humans. Thus, we utilized pregnant rats as an in vivo model to investigate the potential effects of TiO2 NPs on placental development and to uncover the potential underlying mechanisms. Rats have a gestation period of 21 days, with embryos being implanted around 4–5 days after fertilization. Therefore, we selected the 5th day of pregnancy as the starting point for exposure. Throughout this study, we closely monitored maternal changes and recorded pregnancy outcomes after TiO2 NPs exposures, with a particular emphasis on observing placental development to elucidate the potential mechanisms at play.

2. Materials and Methods

2.1. Animals

The animal study was conducted in compliance with the ethical guidelines set forth by the Nanjing Medical University Ethics Committee (Approved No: IACUC-24040115) and followed the principles outlined in the ARRIVE Guidelines for reporting in vivo experiments. Titanium dioxide nanoparticles (TiO2 NPs, CAS number: 13463-67-7) were purchased from Sigma-Aldrich(Sigma Chemical Co., St. Louis, MO, USA). Adult male and female SD rats (8 weeks, 280–300 g) were obtained from Beijing Vital River Laboratory Animal Technology Co., Ltd. All rats were housed separately, by gender, and acclimatized in a controlled environment maintained at a temperature of 22 ± 2 °C and humidity of 40–60%, with a 12 h light/dark cycle, for one week of rest prior to the commencement of the experiments. Female rats were paired with males in a 1:1 ratio following random grouping, with 10 rats in each group. Male rats were separated from females after confirming the presence of a vaginal plug every morning, and this was recorded as gestational day 0.5 (GD 0.5).

2.2. Cell Culture

Trophoblastic cells (HTR8-Svneo) were purchased from American Type Culture Collection (ATCC® CRL-3271™) and cultured in Roswell Park Memorial Institute 1640 (RPMI-1640) medium supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 μg/mL streptomycin. The culture dishes were incubated in a 37 °C, 5% CO2 atmosphere, and the medium was replaced every day.

2.3. TiO2 NPs Preparation and Exposure Design

The TiO2 NPs were dispersed in a 5% methylcellulose solution at a concentration of 5 mg/mL. Their characteristics were assessed following sonication at 100 W for 30 min. A morphological analysis was conducted using transmission electron microscopy (TEM), while their hydrodynamic diameter was determined using dynamic light scattering (DLS). To mimic human exposure routes and doses, pregnant rats were orally administered TiO2 NPs at a dose of 5 mg/kg body weight per day from GD5 to GD18 during pregnancy. Control rats received treatment with a 0.5% methylcellulose solution [16]. The dose of 5 mg/kg/day was selected based on the average daily human consumption of TiO2 [17]. Following delivery, except for those euthanized for further analysis, the remaining female rats ceased their TiO2 NP exposure. Throughout the study, all pregnant rats were monitored for weight changes before supplying food.

2.4. Tissue Collection and Preparation

The pregnant rats were euthanized using 10% chloral hydrate on gestational day 18 (GD 18). Subsequently, maternal organs including the liver, spleen, kidney, and placenta were carefully dissected, counted, and weighed to calculate the organ coefficients (weight of the organ/total body weight) and then preserved in 4% polyformaldehyde for subsequent analysis. Pregnancy outcomes including fetal numbers and fetal growth conditions were documented simultaneously. To prevent the separation of the placenta from the uterus, the placenta–uterus units were carefully kept intact, ensuring the preservation of the placental invasion ability for subsequent analyses.

2.5. Histopathological Analysis and Immunohistochemical Analysis

The tissues were fixed and dehydrated before being embedded in paraffin. Subsequently, tissue blocks were sectioned into slices. These slices underwent dewaxing with xylene, followed by rehydration with graded alcohol. Hematoxylin and eosin (HE) staining and periodic acid-Schiff (PAS) staining were performed using a commercial kit and antibody (Beyotime, C0105, Shanghai, China; Abcam, ab150680, Cambridge, UK), following the manufacturer’s instructions. PAS staining was employed to highlight the elastic fibers, collagen, and other components in the kidney. The immunohistochemical analysis was conducted using an anti-LC3B antibody (Abcam, ab48394) in conjunction with an HRP-conjugated secondary antibody. All sections were examined under a light microscope, and images were semi-quantified using ImageJ Software 1.8.0 (National Institute of Health, USA).

2.6. Placenta Invasion Ability Assessment

The placental invasion ability assessment was conducted following the methodology outlined in a previous study [18]. The percentage of interstitial trophoblast invasion into the mesometrial triangle (MT) was utilized to quantify the invasion ability, with infiltrated trophoblast cells identified using a cytokeratin-7 (CK-7) antibody (Abcam, ab181598). Evidence of spiral artery (SA) remodeling was also identified through the presence of CK-7-positive cells arranged on a fibrinoid layer, alongside the absence of α-actin-positive smooth muscle cells. Additionally, the cross-sectional area, as reported by Cotechini et al., was included as an informative indicator [19]. Both the ratio of the cytokeratin-7-positive trophoblast cell area to the MT area and the cross-sectional areas were measured using image J analysis software.

2.7. Immunofluorescence Analysis

A trophoblastic cell (HTR8-Svneo) model was employed for in vitro mechanism verification. Cellular autophagy levels were assessed using an anti-LC3B antibody in conjunction with a confocal microscope. Cells were seeded onto specialized dishes and incubated with 10 μg/mL TiO2 NPs. After exposure for 24 h, cells were fixed and treated with the primary antibody overnight, followed by a CY3-labeled secondary antibody. Images were captured using a confocal microscope system.

2.8. Cell Invasion and Migration Ability Analysis

Cell invasion and migration ability were evaluated using a transwell assay. In brief, HTR cells were exposed to 10 μg/mL TiO2 NPs and suspended in serum-free medium. These cells were then seeded onto matrigel-coated upper chambers, while a serum-containing medium was added to the lower chambers. After a 24 h incubation period, the cells were fixed and stained with crystal violet, and the number of penetrated cells was counted using a light microscope.

2.9. Maternal Blood Pressure Monitoring

Maternal mean arterial pressure (MAP) was assessed using a non-invasive blood pressure analyzer on GD0 (before mating), GD18, and the third day after delivery (AD3) in both experimental groups. The research was conducted in a controlled environment to minimize noise, with room temperature maintained between 25 and 26 °C. Female rats were gently restrained, and the pressure detector was securely positioned on their tails. Once the animals had calmed for approximately 3 min, the measurements were initiated. Each rat underwent 6 consecutive series of measurements, and any aberrant data points were excluded from the analysis.

2.10. Determination of Proteinuria

Spot urine samples from female rats in both experimental groups were collected at the corresponding time points to assess the occurrence of proteinuria, as previously described [20]. Urinary albumin and urine creatinine concentrations were quantified using commercial assay kits (TRFIA) (Lumigenx, Suzhou, China) following the manufacturer’s instructions. The albumin to creatinine ratio (ACR) was utilized as an indicator of proteinuria.

2.11. Statistical Analysis

Statistical analyses were performed using SPSS software(IBM, Armonk, NY, USA). The normality and homogeneity of variance for all data were assessed using the Kolmogorov–Smirnov test. Quantitative data were presented as mean ± SD. The comparison of differences between two groups or among multiple groups was conducted using the t-test and a one-way ANOVA, respectively. The difference between the two ratios was assessed using the Chi-square test. A p-value of less than 0.05 was considered statistically significant.

3. Results

3.1. Main Characteristics of TiO2 NPs

The main characteristics of TiO2 NPs in 0.5% methylcellulose and in cell culture medium were determined and are presented in Figure 1A. The transmission electron microscopy (TEM) results (Figure 1B) revealed that the morphology of TiO2 NPs was nearly spherical, with a primary size of approximately 21 nm. The purity of the TiO2 NPs was reported to be ≥99.5% in terms of trace metals, with a BET surface area ranging from 35 to 65 m2/g, and their crystal form was determined to be 80% anatase and 20% rutile according to the manufacturer’s reports. Additionally, the results of dynamic light scattering (DLS) indicated that the average hydrodynamic diameter of the TiO2 NPs was approximately 190 nm in 0.5% methylcellulose and about 80 nm in complete cell culture medium containing serum, which is consistent with our previous study.

3.2. Effects of TiO2 NPs on Maternal Conditions

The results revealed that the conception rate, with both groups showing 7 or 8 out of 9 successful conceptions, exhibited no difference after the observation of vaginal plugs. Maternal body weight and organ weights were recorded before and after the TiO2 NPs exposure. The monitoring of body weight indicated that the maternal body weight did not differ at the beginning of the study but increased throughout the entire pregnancy period in both groups, with a significant difference observed at the end stage of pregnancy, while the body weight gain (BWG) showed no significant change (Figure 1C). Additionally, compared to control rats, the weight of the maternal liver, kidney, spleen, and their corresponding organ coefficients, all increased on GD18 following exposure. Conversely, the weight of the ovary and the ovarian coefficient showed no significant change between the two groups on GD18 (Figure 1D).

3.3. Pathological Changes of Maternal Organs after TiO2 NPs Exposure

The maternal liver, kidney, spleen and ovary were examined by hematoxylin–eosin (HE) staining. Compared with the control group, hyperemia occurred in the liver after exposure, resulting in an edema and the degeneration of liver cells in the hyperemic areas, with degenerative particles appearing in the cytoplasm. This occurred partly, rather than diffusing throughout the entire organ. After the TiO2 NPs exposure, we observed that the volume of glomeruli increased and the renal tubular cells exhibited edema. The maternal splenic corpuscles either disappeared or were demolished, with splenic sinusoids exhibiting hyperemia. The area of white pulp decreased, indicating atrophy of the white pulp. Additionally, the splenic marginal zone widened. In comparison to the control group, the maternal ovary showed no pathological changes after exposure (Figure 2).

3.4. Effects of TiO2 NPs on Fetal Birth Outcomes

Compared with the control group, the early embryo resorption rate significantly increased after an exposure to TiO2 NPs, with a ratio of 0.019 (2/105) in the control group and 0.0737 (7/95) in the exposure group. Moreover, the number of pregnant rats experiencing embryo loss significantly increased (2/7 in the control group and 5/8 in the exposure group). Even a monocyesis was observed after exposure, which barely happens during normal pregnancy (Figure S1). Although there was a decreasing trend, the total number and total weight of the fetuses (including the fetus, placenta, and uterus) did not show a significant difference after their exposure to TiO2 NPs (Figure 3A,B). However, the average body weight (Figure 3C) and body length (Figure 3D,E) of the fetal rats decreased significantly (p < 0.05). The average placental diameters showed no difference (Figure 3G,H), while their corresponding weights exhibited a slight but significant increase (0.05 g) in the exposure group (Figure 3F).

3.5. TiO2 NPs Increased Maternal Mean Arterial Pressure (MAP)

Maternal mean arterial pressures (MAPs) were measured on GD0 (before mating), GD18, and on the third day after delivery (AD3). The blood pressure monitoring results indicated no significant difference between the two groups on GD0. However, the MAP significantly increased in the exposure group on GD18 (Figure 4A). Furthermore, even after delivery, their maternal MAPs remained significantly higher than those of the control rats, indicating irreversible damage to the mothers.

3.6. TiO2 NPs Induced Maternal Proteinuria

Maternal proteinuria was assessed on GD0, GD18, and AD3. The findings revealed that, after adjusting for the effects of creatinine, the albumin-to-creatinine ratio (ACR) significantly increased in the TiO2 NPs exposure group on GD18, indicating the occurrence of proteinuria (Figure 4B). Moreover, the proteinuria persisted on the third day after delivery, showing no signs of diminishing.

3.7. Effects of TiO2 NPs on Placental Infiltration into Uterus

Placental infiltration and spiral artery (SA) remodeling were assessed using image analysis software after revealing interstitial trophoblastic cells and smooth muscle cells. The immunohistochemistry results indicated a decreased ratio of cytokeratin-positive and an increased ratio of actin-positive cells in SA (Figure 5A,B). The area percentage of interstitial trophoblast invasion into the maternal tissue (MT) significantly decreased after the maternal exposure to TiO2 NPs (Figure 5C). Additionally, a reduction in both the number and cross-section areas of the spiral arteries (SAs) in the placental triangle was observed in the TiO2 NPs group compared to the control group (Figure 5D).

3.8. Effects of TiO2 NPs on Maternal Glomerular Basement Membrane (GBM)

This glomerulus was stained with PAS to reveal the basement membranes. As shown in Figure 6A, after the TiO2 NPs exposure, the capillary loops of the glomerulus were thin and well defined, while the loops were blurred and the normal structures had disappeared, indicating that the GBM was destroyed. A fibrinous deposition was easily observed in the glomerulus. Figure 6B showed the ultra-microstructure observed by TEM; as shown, the control tissue showed a clear and consecutive GBM, while the GBM in the exposure group was fuzzy and became thin, fractures even occurred in certain areas.

3.9. Effects of TiO2 NPs on the Migration and Invasion Ability of Human Trophoblastic Cells

The migration and invasion abilities of human trophoblastic cells were assessed using a transwell assay. The results (Figure 7A) revealed that, after an exposure to 10 μg/mL TiO2 NPs, the number of penetrated cells significantly decreased when observed under a light microscope.

3.10. Effects of TiO2 NPs on the Autophagy of Human Trophoblastic Cells

The autophagy levels of HTR cells were assessed through immunofluorescence combined with a confocal microscope examination following their exposure to 10 μg/mL TiO2 NPs. Figure 7B showed that, after the exposure of TiO2 NPs, there was an observed increase in the autophagy level of HTR cells. Specifically, in the control cells, there were few LC3-positive dots, whereas, in the treated group, numerous autophagosomes formed and accumulated in the cytoplasm.

4. Discussion

Due to the widespread use of TiO2 NPs in everyday products and the indications of their toxicity to humans from numerous animal studies [21,22], concerns regarding their safety for human beings, particularly pregnant women, have been raised. However, to date, there is limited epidemiological evidence proving the risks of TiO2 NPs to pregnant women and their fetuses. Therefore, establishing pregnant animal models is essential to explore the potential effects following from TiO2 NPs exposures. In a previous study, Yamashita et al. established a pregnant mice model to investigate the adverse effects of TiO2 NPs on maternal and fetal health. They found that the placenta played a significant role as a target organ in mediating toxicity during pregnancy [23]. However, it has been suggested that the rat placenta may be more suitable for studying human placental function, considering the similarities in its trophoblastic cell invasion and spiral arterial remodeling [24]. In this study, we opted for a pregnant rat model as it represents a suitable model and we primarily focused on placental development after TiO2 NPs exposures.
To our knowledge, pregnant females are sensitive to their surroundings and to different manipulations, which can sometimes lead to abortion during the early stages of pregnancy [25]. However, our results indicated that the conception rate did not differ between the two groups, suggesting that the effects of manual manipulation could be disregarded. We observed that the maternal body weight across the two groups significantly increased from the 12th day. We attribute this finding to the complex changes involving organ weights and fetal weights, as well as the enhanced maternal blood glucose level reported in our previous study [26]. Specifically, major maternal organs such as the liver, kidney, and spleen exhibited hyperemia, with both organ weight and organ coefficient showing significant increases. Meanwhile, the total fetal weight decreased, a phenomenon also reported in Hong’s study [27].
Previous studies evaluating TiO2 NPs’ toxicity have shown similar pathological changes in the liver, with researchers attributing these changes to inflammatory responses or disturbances in the antioxidant system [28]. The kidney, which is the main organ for TiO2 NPs’ excretion [29], exhibited glomerular swelling and an accumulation of red blood cells after exposure, consistent with previous findings [30]. This alteration may result from inflammation, as similar results have been reported in other studies [31]. The spleen, an important immune organ, contains numerous macrophages at its edges, which play a crucial role in responding to foreign substances [32]. In our study, we observed a widening of the spleen edge after exposure, indicating a vigorous immune response, consistent with previous findings that TiO2 NPs prime a specific activation state of macrophages [33]. Additionally, a previous study demonstrated that TiO2 NPs exert immune toxicity by inducing apoptosis and Toll-like receptor signaling [34], a finding supported by the observed atrophy of the white pulp in our study.
Researchers have found that TiO2 NPs can induce premature ovarian failure, follicle disorders, and ovarian dysfunction in female mice [35,36,37], indicating reproductive toxicity in this species. However, no obvious pathological changes were observed in the present study. This might be explained by the fact that, during pregnancy, follicle development halts and its blood supply decreases compared to that in non-pregnant females, potentially reducing the impact on the ovary, similar to the kidney responses.
Following the exposure to TiO2 NPs, there was a significant increase in embryo loss, consistent with a previous finding [38]. Our results, along with those of previous reports, suggest that TiO2 NPs may increase the abortion rate in humans after maternal exposure. Decreases in average body weight and length suggest inhibited fetal development, raising concerns about the potential associations between TiO2 NPs exposure and low fetal birth weight or fetal growth restriction (FGR) in humans. As far as our knowledge extends, the placenta plays a crucial role in embryo development, and the failure of proper placental invasion can lead to abnormal fetal development. Therefore, placental infiltration was further evaluated in our study.
The migration and invasion of trophoblast cells are known to be associated with the maternal vascular network [39], and the invasion of trophoblast cells into the spiral arteries is a critical process for vascular remodeling during pregnancy. Therefore, we evaluated indicators closely related to placental development, including the percentage of the area invaded by trophoblast cells in the mesometrial triangles, the presence of trophoblast cells resting on a fibrinoid layer [18], and the cross-sectional area of the spiral arteries [19]. Our results suggested an insufficient invasion of the placenta into the endometrium and a failure to complete spiral artery remodeling. This restricted fetal blood supply and affected fetal development, resulting in decreased fetal weight and length in the exposure group, resembling the progression of preeclampsia.
Inflammatory responses, cell apoptosis, and reactive oxygen species (ROS) were observed in a placenta model after a maternal exposure to TiO2 NPs [40,41]. The authors suggested these as possible mechanisms for placental vascular dysfunction. Recent studies have shown that autophagy is an important mechanism contributing to placental dysplasia [42]. Additionally, TiO2 NPs have been reported to induce autophagy in various cell lines [43], potentially inhibiting the normal development of the rat placenta by inducing autophagy in trophoblastic cells. Therefore, we investigated whether autophagy plays a crucial role in TiO2 NPs-induced placental dysfunction. Our results showed a significant increase in autophagy levels in the labyrinthine placenta after exposure. The evidence indicates that TiO2 NPs can accumulate in the placenta and reach relatively high levels even after exposure during pregnancy [27]. To verify whether TiO2 NPs could induce autophagy at relatively low doses, we administered 10 μg/mL of TiO2 NPs to HTR, a human-derived cell line, for further study. The results confirmed that TiO2 NPs could induce cell autophagy and inhibit the migration and invasion ability of human trophoblastic cells, validating the results observed in animal studies and raising concerns about the risks to pregnant women.
Considering that TiO2 NPs induced significant pathological and functional changes in both the kidney and placenta, resembling those seen in preeclampsia, our study observed increased blood pressure and the appearance of proteinuria after exposure, on GD18. Previous animal studies suggested that TiO2 NPs may deposit on the glomerular basement membrane, inducing kidney inflammation, although the total urine protein levels did not significantly change [44]. In our study, proteinuria was detected, potentially indicating an increased kidney burden during pregnancy and protein leakage. It has been reported that nanoparticles can induce kidney injury and elevate urinary retinol-binding proteins, supporting our findings [45]. The kidney plays a crucial role in blood pressure regulation [46], and TiO2 has been shown to activate ROS [47] or induce fibrosis via the Wnt pathway [48], thus contributing to increased blood pressure through renal impairment via reported or undetermined pathways after a TiO2 NPs exposure. An important characteristic of preeclampsia is the resolution of hypertension and proteinuria after delivery. However, in our study, hypertension and proteinuria did not revert to pre-pregnancy levels. It is important to note that the disease induced by TiO2 NPs is not traditional preeclampsia, and treatments for preeclampsia may not be effective and could potentially exacerbate these related clinical symptoms during pregnancy. In our previous work, we identified targets for reversing autophagy to mitigate the adverse effects of TiO2 NPs during human placental development [49]. However, considering that microRNAs are species-specific and the candidate microRNAs identified in human trophoblastic cells may not be suitable for use in rats, we were unable to observe birth outcomes and placental development after reversing placental autophagy. Nonetheless, targeting autophagy reversal may be a useful approach to alleviating TiO2 NPs-related symptoms in pregnant women.

5. Conclusions

In this study, we demonstrated that pregnant rats exposed to TiO2 NPs via their digestive tract from GD5 to GD18 exhibited significant alterations in maternal physiology, organ pathology, fetal growth restriction, and a maternal preeclampsia-like syndrome. The adverse effects on the fetus and mother may be associated with placental dysplasia, which may be related to deficiencies in autophagy-related cell migration and invasion. Overall, TiO2 NPs induced symptoms resembling those of preeclampsia in pregnant rats.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/toxics12050367/s1, Figure S1: The image of the maternal uterus that carried single pregnancy.

Author Contributions

H.L. carried out the animal study and wrote the manuscript, H.H. was responsible for the cell study, D.M. was responsible for the data analysis, P.X. guided the placenta function assessment, Z.M. and K.Z. designed the study and provided the funding support, K.Z. also helped to revise the draft. All authors have read and agreed to the published version of the manuscript.

Funding

The study was founded by Social Developmental Project of Changzhou Science and Technology Bureau (CE20215037); Top Talent of Changzhou “The 14th FiveYear Plan” High-Level Health Talents Training Project (2022CZLJ088).

Institutional Review Board Statement

The animal study protocol was approved by the Ethics Committee of Nanjing Medical University (IACUC-24040115).

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Baranowska-Wojcik, E.; Szwajgier, D.; Oleszczuk, P.; Winiarska-Mieczan, A. Effects of Titanium Dioxide Nanoparticles Exposure on Human Health—A Review. Biol. Trace Elem. Res. 2019, 193, 118–129. [Google Scholar] [CrossRef]
  2. Warheit, D.B.; Donner, E.M. Risk assessment strategies for nanoscale and fine-sized titanium dioxide particles: Recognizing hazard and exposure issues. Food Chem. Toxicol. 2015, 85, 138–147. [Google Scholar] [CrossRef] [PubMed]
  3. Gulson, B.; McCall, M.J.; Bowman, D.M.; Pinheiro, T. A review of critical factors for assessing the dermal absorption of metal oxide nanoparticles from sunscreens applied to humans, and a research strategy to address current deficiencies. Arch. Toxicol. 2015, 89, 1909–1930. [Google Scholar] [CrossRef] [PubMed]
  4. Shi, H.; Magaye, R.; Castranova, V.; Zhao, J. Titanium dioxide nanoparticles: A review of current toxicological data. Part. Fibre Toxicol. 2013, 10, 15. [Google Scholar] [CrossRef]
  5. Takeda, K.; Shinkai, Y.; Suzuki, K.; Yanagita, S.; Umezawa, M.; Yokota, S.; Tainaka, H.; Oshio, S.; Ihara, T.; Sugamata, M. Health effects of nanomaterials on next generation. Yakugaku Zasshi 2011, 131, 229–236. [Google Scholar] [CrossRef]
  6. Warheit, D.B. Hazard and risk assessment strategies for nanoparticle exposures: How far have we come in the past 10 years? F1000Research 2018, 7, 376. [Google Scholar] [CrossRef]
  7. Grande, F.; Tucci, P. Titanium Dioxide Nanoparticles: A Risk for Human Health? Mini Rev. Med. Chem. 2016, 16, 762–769. [Google Scholar] [CrossRef] [PubMed]
  8. Naserzadeh, P.; Ghanbary, F.; Ashtari, P.; Seydi, E.; Ashtari, K.; Akbari, M. Biocompatibility assessment of titanium dioxide nanoparticles in mice fetoplacental unit. J. Biomed. Mater. Res. A 2018, 106, 580–589. [Google Scholar] [CrossRef]
  9. Hong, F.; Zhou, Y.; Ji, J.; Zhuang, J.; Sheng, L.; Wang, L. Nano-TiO2 Inhibits Development of the Central Nervous System and Its Mechanism in Offspring Mice. J. Agric. Food Chem. 2018, 66, 11767–11774. [Google Scholar] [CrossRef]
  10. Burton, G.J.; Fowden, A.L. The placenta: A multifaceted, transient organ. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2015, 370, 20140066. [Google Scholar] [CrossRef]
  11. Silva, J.F.; Serakides, R. Intrauterine trophoblast migration: A comparative view of humans and rodents. Cell Adh. Migr. 2016, 10, 88–110. [Google Scholar] [CrossRef]
  12. Salavati, N.; Smies, M.; Ganzevoort, W.; Charles, A.K.; Erwich, J.J.; Plosch, T.; Gordijn, S.J. The Possible Role of Placental Morphometry in the Detection of Fetal Growth Restriction. Front. Physiol. 2018, 9, 1884. [Google Scholar] [CrossRef]
  13. Zong, S.; Li, C.; Luo, C.; Zhao, X.; Liu, C.; Wang, K.; Jia, W.; Bai, M.; Yin, M.; Bao, S.; et al. Dysregulated expression of IDO may cause unexplained recurrent spontaneous abortion through suppression of trophoblast cell proliferation and migration. Sci. Rep. 2016, 6, 19916. [Google Scholar] [CrossRef]
  14. Lyall, F.; Robson, S.C.; Bulmer, J.N. Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction: Relationship to clinical outcome. Hypertension 2013, 62, 1046–1054. [Google Scholar] [CrossRef] [PubMed]
  15. Gutierrez, J.A.; Gomez, I.; Chiarello, D.I.; Salsoso, R.; Klein, A.D.; Guzman-Gutierrez, E.; Toledo, F.; Sobrevia, L. Role of proteases in dysfunctional placental vascular remodelling in preeclampsia. Biochim. Biophys. Acta Mol. Basis Dis. 2019, 1866, 165448. [Google Scholar] [CrossRef]
  16. Auttachoat, W.; McLoughlin, C.E.; White, K.L., Jr.; Smith, M.J. Route-dependent systemic and local immune effects following exposure to solutions prepared from titanium dioxide nanoparticles. J. Immunotoxicol. 2014, 11, 273–282. [Google Scholar] [CrossRef]
  17. Jovanović, B. Critical review of public health regulations of titanium dioxide, a human food additive. Integr. Environ. Assess. Manag. 2015, 11, 10–20. [Google Scholar] [CrossRef] [PubMed]
  18. Vercruysse, L.; Caluwaerts, S.; Luyten, C.; Pijnenborg, R. Interstitial trophoblast invasion in the decidua and mesometrial triangle during the last third of pregnancy in the rat. Placenta 2006, 27, 22–33. [Google Scholar] [CrossRef]
  19. Cotechini, T.; Komisarenko, M.; Sperou, A.; Macdonald-Goodfellow, S.; Adams, M.A.; Graham, C.H. Inflammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restriction and features of preeclampsia. J. Exp. Med. 2014, 211, 165–179. [Google Scholar] [CrossRef]
  20. Aziz, K.M.A. Association of High Levels of Spot Urine Protein with High Blood Pressure, Mean Arterial Pressure and Pulse Pressure with Development of Diabetic Chronic Kidney Dysfunction or Failure among Diabetic Patients. Statistical Regression Modeling to Predict Diabetic Proteinuria. Curr. Diabetes Rev. 2018, 15, 486–496. [Google Scholar]
  21. Asare, N.; Duale, N.; Slagsvold, H.H.; Lindeman, B.; Olsen, A.K.; Gromadzka-Ostrowska, J.; Meczynska-Wielgosz, S.; Kruszewski, M.; Brunborg, G.; Instanes, C. Genotoxicity and gene expression modulation of silver and titanium dioxide nanoparticles in mice. Nanotoxicology 2016, 10, 312–321. [Google Scholar] [CrossRef] [PubMed]
  22. Ebrahimzadeh Bideskan, A.; Mohammadipour, A.; Fazel, A.; Haghir, H.; Rafatpanah, H.; Hosseini, M.; Rajabzadeh, A. Maternal exposure to titanium dioxide nanoparticles during pregnancy and lactation alters offspring hippocampal mRNA BAX and Bcl-2 levels, induces apoptosis and decreases neurogenesis. Exp. Toxicol. Pathol. 2017, 69, 329–337. [Google Scholar] [CrossRef] [PubMed]
  23. Yamashita, K.; Yoshioka, Y.; Higashisaka, K.; Mimura, K.; Morishita, Y.; Nozaki, M.; Yoshida, T.; Ogura, T.; Nabeshi, H.; Nagano, K.; et al. Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nat. Nanotechnol. 2011, 6, 321–328. [Google Scholar] [CrossRef] [PubMed]
  24. Grigsby, P.L. Animal Models to Study Placental Development and Function throughout Normal and Dysfunctional Human Pregnancy. Semin. Reprod. Med. 2016, 34, 11–16. [Google Scholar] [CrossRef] [PubMed]
  25. Bettahar, K.; Pinton, A.; Boisrame, T.; Cavillon, V.; Wylomanski, S.; Nisand, I.; Hassoun, D. Medical induced abortion. J. Gynecol. Obstet. Biol. Reprod. 2016, 45, 1490–1514. [Google Scholar] [CrossRef]
  26. Mao, Z.; Li, Y.; Dong, T.; Zhang, L.; Zhang, Y.; Li, S.; Hu, H.; Sun, C.; Xia, Y. Exposure to Titanium Dioxide Nanoparticles During Pregnancy Changed Maternal Gut Microbiota and Increased Blood Glucose of Rat. Nanoscale Res. Lett. 2019, 14, 26. [Google Scholar] [CrossRef]
  27. Hong, F.; Zhou, Y.; Zhao, X.; Sheng, L.; Wang, L. Maternal exposure to nanosized titanium dioxide suppresses embryonic development in mice. Int. J. Nanomed. 2017, 12, 6197–6204. [Google Scholar] [CrossRef] [PubMed]
  28. Shakeel, M.; Jabeen, F.; Iqbal, R.; Chaudhry, A.S.; Zafar, S.; Ali, M.; Khan, M.S.; Khalid, A.; Shabbir, S.; Asghar, M.S. Assessment of Titanium Dioxide Nanoparticles (TiO2-NPs) Induced Hepatotoxicity and Ameliorative Effects of Cinnamomum cassia in Sprague-Dawley Rats. Biol. Trace Elem. Res. 2018, 182, 57–69. [Google Scholar] [CrossRef]
  29. Cho, W.S.; Kang, B.C.; Lee, J.K.; Jeong, J.; Che, J.H.; Seok, S.H. Comparative absorption, distribution, and excretion of titanium dioxide and zinc oxide nanoparticles after repeated oral administration. Part. Fibre Toxicol. 2013, 10, 9. [Google Scholar] [CrossRef]
  30. Alidadi, H.; Khorsandi, L.; Shirani, M. Effects of Quercetin on Tubular Cell Apoptosis and Kidney Damage in Rats Induced by Titanium Dioxide Nanoparticles. Malays. J. Med. Sci. 2018, 25, 72–81. [Google Scholar] [CrossRef]
  31. Hong, F.; Wu, N.; Ge, Y.; Zhou, Y.; Shen, T.; Qiang, Q.; Zhang, Q.; Chen, M.; Wang, Y.; Wang, L.; et al. Nanosized titanium dioxide resulted in the activation of TGF-beta/Smads/p38MAPK pathway in renal inflammation and fibration of mice. J. Biomed. Mater. Res. A 2016, 104, 1452–1461. [Google Scholar] [CrossRef]
  32. Mebius, R.E.; Kraal, G. Structure and function of the spleen, Nature reviews. Immunology 2005, 5, 606–616. [Google Scholar]
  33. Huang, C.; Sun, M.; Yang, Y.; Wang, F.; Ma, X.; Li, J.; Wang, Y.; Ding, Q.; Ying, H.; Song, H.; et al. Titanium dioxide nanoparticles prime a specific activation state of macrophages. Nanotoxicology 2017, 11, 737–750. [Google Scholar] [CrossRef]
  34. Dhupal, M.; Oh, J.M.; Tripathy, D.R.; Kim, S.K.; Koh, S.B.; Park, K.S. Immunotoxicity of titanium dioxide nanoparticles via simultaneous induction of apoptosis and multiple toll-like receptors signaling through ROS-dependent SAPK/JNK and p38 MAPK activation. Int. J. Nanomed. 2018, 13, 6735–6750. [Google Scholar] [CrossRef]
  35. Hong, F.; Wang, L. Nanosized titanium dioxide-induced premature ovarian failure is associated with abnormalities in serum parameters in female mice. Int. J. Nanomed. 2018, 13, 2543–2549. [Google Scholar] [CrossRef]
  36. Zhao, X.; Ze, Y.; Gao, G.; Sang, X.; Li, B.; Gui, S.; Sheng, L.; Sun, Q.; Cheng, J.; Cheng, Z.; et al. Nanosized TiO2-induced reproductive system dysfunction and its mechanism in female mice. PLoS ONE 2013, 8, e59378. [Google Scholar] [CrossRef]
  37. Gao, G.; Ze, Y.; Li, B.; Zhao, X.; Zhang, T.; Sheng, L.; Hu, R.; Gui, S.; Sang, X.; Sun, Q.; et al. Ovarian dysfunction and gene-expressed characteristics of female mice caused by long-term exposure to titanium dioxide nanoparticles. J. Hazard. Mater. 2012, 243, 19–27. [Google Scholar] [CrossRef]
  38. Philbrook, N.A.; Winn, L.M.; Afrooz, A.R.; Saleh, N.B.; Walker, V.K. The effect of TiO(2) and Ag nanoparticles on reproduction and development of Drosophila melanogaster and CD-1 mice. Toxicol. Appl. Pharmacol. 2011, 257, 429–436. [Google Scholar] [CrossRef] [PubMed]
  39. Pijnenborg, R.; Vercruysse, L.; Hanssens, M. The uterine spiral arteries in human pregnancy: Facts and controversies. Placenta 2006, 27, 939–958. [Google Scholar] [CrossRef]
  40. Yin, F.; Zhu, Y.; Zhang, M.; Yu, H.; Chen, W.; Qin, J. A 3D human placenta-on-a-chip model to probe nanoparticle exposure at the placental barrier. Toxicol. In Vitro 2019, 54, 105–113. [Google Scholar] [CrossRef]
  41. Zhang, L.; Xie, X.; Zhou, Y.; Yu, D.; Deng, Y.; Ouyang, J.; Yang, B.; Luo, D.; Zhang, D.; Kuang, H. Gestational exposure to titanium dioxide nanoparticles impairs the placentation through dysregulation of vascularization, proliferation and apoptosis in mice. Int. J. Nanomed. 2018, 13, 777–789. [Google Scholar] [CrossRef]
  42. Huang, X.; Han, X.; Huang, Z.; Yu, M.; Zhang, Y.; Fan, Y.; Xu, B.; Zhou, K.; Song, L.; Wang, X.; et al. Maternal pentachlorophenol exposure induces developmental toxicity mediated by autophagy on pregnancy mice. Ecotoxicol. Environ. Saf. 2019, 169, 829–836. [Google Scholar] [CrossRef]
  43. Dai, X.; Liu, R.; Li, N.; Yi, J. Titanium dioxide nanoparticles induce in vitro autophagy. Hum. Exp. Toxicol. 2019, 38, 56–64. [Google Scholar] [CrossRef] [PubMed]
  44. Valentini, X.; Rugira, P.; Frau, A.; Tagliatti, V.; Conotte, R.; Laurent, S.; Colet, J.M.; Nonclercq, D. Hepatic and Renal Toxicity Induced by TiO2 Nanoparticles in Rats: A Morphological and Metabonomic Study. J. Toxicol. 2019, 2019, 5767012. [Google Scholar] [CrossRef]
  45. Fontana, L.; Leso, V.; Marinaccio, A.; Cenacchi, G.; Papa, V.; Leopold, K.; Schindl, R.; Bocca, B.; Alimonti, A.; Iavicoli, I. The effects of palladium nanoparticles on the renal function of female Wistar rats. Nanotoxicology 2015, 9, 843–851. [Google Scholar] [CrossRef] [PubMed]
  46. Sato, R.; Luthe, S.K.; Nasu, M. Blood pressure and acute kidney injury. Crit. Care 2017, 21, 28. [Google Scholar] [CrossRef]
  47. Niu, L.; Shao, M.; Liu, Y.; Hu, J.; Li, R.; Xie, H.; Zhou, L.; Shi, L.; Zhang, R.; Niu, Y. Reduction of oxidative damages induced by titanium dioxide nanoparticles correlates with induction of the Nrf2 pathway by GSPE supplementation in mice. Chem.-Biol. Interact. 2017, 275, 133–144. [Google Scholar] [CrossRef]
  48. Hong, F.; Hong, J.; Wang, L.; Zhou, Y.; Liu, D.; Xu, B.; Yu, X.; Sheng, L. Chronic exposure to nanoparticulate TiO2 causes renal fibrosis involving activation of the Wnt pathway in mouse kidney. J. Agric. Food Chem. 2015, 63, 1639–1647. [Google Scholar] [CrossRef]
  49. Mao, Z.; Yao, M.; Li, Y.; Fu, Z.; Li, S.; Zhang, L.; Zhou, Z.; Tang, Q.; Han, X.; Xia, Y. miR-96-5p and miR-101-3p as potential intervention targets to rescue TiO2 NP-induced autophagy and migration impairment of human trophoblastic cells. Biomater. Sci. 2018, 6, 3273–3283. [Google Scholar] [CrossRef]
Toxics 12 00367 g001
Figure 1. (A,B) The characteristics of TiO2 NPs determined by a transmission electronic microscope (TEM), dynamic light scattering (DLS), and by the manufacturer’s report. (C) Maternal body weights were determined before the female rats were fed every morning. Body weight gain (BWG) = (mf − mi)/mi. “mf” represents the final body weight and “mi” represents the initial body weight. (D) The main organs (liver, kidney, spleen, and ovary) were weighed and the organ coefficients were calculated after the pregnant rats were executed on GD18. * p < 0.05, ** p < 0.01, *** p < 0.001. There were 7 rats in the control group and 8 rats in the exposure group.
Figure 1. (A,B) The characteristics of TiO2 NPs determined by a transmission electronic microscope (TEM), dynamic light scattering (DLS), and by the manufacturer’s report. (C) Maternal body weights were determined before the female rats were fed every morning. Body weight gain (BWG) = (mf − mi)/mi. “mf” represents the final body weight and “mi” represents the initial body weight. (D) The main organs (liver, kidney, spleen, and ovary) were weighed and the organ coefficients were calculated after the pregnant rats were executed on GD18. * p < 0.05, ** p < 0.01, *** p < 0.001. There were 7 rats in the control group and 8 rats in the exposure group.
Toxics 12 00367 g001
Toxics 12 00367 g002
Figure 2. The pathological changes in the maternal liver, kidney, spleen, and ovary after exposure were examined by light microscope after hematoxylin and eosin (HE) staining. Scale bar = 200 μm in the liver, kidney, and spleen. Scale bar = 1000 μm in the ovary. Pathological changes in the liver, kidney, and spleen were indicated with black circles, and hyperemia region was indicated with black square. There were 7 rats in the control group and 8 rats in the exposure group.
Figure 2. The pathological changes in the maternal liver, kidney, spleen, and ovary after exposure were examined by light microscope after hematoxylin and eosin (HE) staining. Scale bar = 200 μm in the liver, kidney, and spleen. Scale bar = 1000 μm in the ovary. Pathological changes in the liver, kidney, and spleen were indicated with black circles, and hyperemia region was indicated with black square. There were 7 rats in the control group and 8 rats in the exposure group.
Toxics 12 00367 g002
Toxics 12 00367 g003
Figure 3. The main birth outcomes were recorded on GD18 after the mothers were executed. The total fetal weight (A), total embryo number (B), average fetal weight (C), average fetal body length (E), average placental weight (F), and placental diameter (G) were obtained from the control and TiO2-treated group. (D,H) show images of the fetuses and placenta. * p < 0.05, ** p < 0.01. There were 105 fetal rats in the control group and 95 fetal rats in the exposure group.
Figure 3. The main birth outcomes were recorded on GD18 after the mothers were executed. The total fetal weight (A), total embryo number (B), average fetal weight (C), average fetal body length (E), average placental weight (F), and placental diameter (G) were obtained from the control and TiO2-treated group. (D,H) show images of the fetuses and placenta. * p < 0.05, ** p < 0.01. There were 105 fetal rats in the control group and 95 fetal rats in the exposure group.
Toxics 12 00367 g003
Toxics 12 00367 g004
Figure 4. (A) The average maternal arterial pressures were measured using a non-invasive blood pressure analyzer before pregnancy (GD0), on the 18th day of gestation (GD18), and on the third day after delivery (AD3). (B) The maternal urinary protein levels were determined using spot urine samples, and the urinary albumin to creatinine ratio (ACR) was utilized to normalize the proteinuria. The data were indicated as mean ± SD. * p < 0.05. There were 7 rats in the control group and 8 rats in the exposure group.
Figure 4. (A) The average maternal arterial pressures were measured using a non-invasive blood pressure analyzer before pregnancy (GD0), on the 18th day of gestation (GD18), and on the third day after delivery (AD3). (B) The maternal urinary protein levels were determined using spot urine samples, and the urinary albumin to creatinine ratio (ACR) was utilized to normalize the proteinuria. The data were indicated as mean ± SD. * p < 0.05. There were 7 rats in the control group and 8 rats in the exposure group.
Toxics 12 00367 g004
Toxics 12 00367 g005
Figure 5. (A) A placental invasion ability assessment was conducted using the percentage of interstitial trophoblast invasion into the mesometrial triangle (MT). The infiltrated trophoblast cells were identified using a cytokeratin-7 (CK-7) antibody. (B) Evidence of spiral artery (SA) remodeling was also identified through the α-actin-positive smooth muscle cells. (C) The ratio of the cytokeratin-7-positive trophoblast cell area to the MT area. (D) The cross-sectional areas and SA numbers were measured by HE staining. A quantitative analysis was carried out with the Olympus OlyVIA software. The data were indicated as mean ± SD. ** p < 0.01, *** p < 0.001. The obvious pathological changes were indicated with black arrows, and the trophoblast invasion areas were outlined. There were 7 rats in the control group and 8 rats in the exposure group.
Figure 5. (A) A placental invasion ability assessment was conducted using the percentage of interstitial trophoblast invasion into the mesometrial triangle (MT). The infiltrated trophoblast cells were identified using a cytokeratin-7 (CK-7) antibody. (B) Evidence of spiral artery (SA) remodeling was also identified through the α-actin-positive smooth muscle cells. (C) The ratio of the cytokeratin-7-positive trophoblast cell area to the MT area. (D) The cross-sectional areas and SA numbers were measured by HE staining. A quantitative analysis was carried out with the Olympus OlyVIA software. The data were indicated as mean ± SD. ** p < 0.01, *** p < 0.001. The obvious pathological changes were indicated with black arrows, and the trophoblast invasion areas were outlined. There were 7 rats in the control group and 8 rats in the exposure group.
Toxics 12 00367 g005
Toxics 12 00367 g006
Figure 6. (A) The glomerular basement membrane (GBM) and deposit of fibrin were revealed by periodic acid-Schiff (PAS) staining. (B) The ultra microstructure of the GBM was revealed by TEM after a series of sample preparations, bar = 1 μm. The glomerular lesions were indicated with black circles, and the fibrin deposition region was indicated with a black square. The normal and impaired GBM were highlighted with black squares in TEM images. There were 7 rats in the control group and 8 rats in the exposure group.
Figure 6. (A) The glomerular basement membrane (GBM) and deposit of fibrin were revealed by periodic acid-Schiff (PAS) staining. (B) The ultra microstructure of the GBM was revealed by TEM after a series of sample preparations, bar = 1 μm. The glomerular lesions were indicated with black circles, and the fibrin deposition region was indicated with a black square. The normal and impaired GBM were highlighted with black squares in TEM images. There were 7 rats in the control group and 8 rats in the exposure group.
Toxics 12 00367 g006
Toxics 12 00367 g007
Figure 7. (A) The cellular migration and invasion ability of trophoblastic cell lines (HTR) were determined by a transwell assay; cell counting was obtained from five independent fields of the light microscope, and the data were presented as mean ± SD, scale bar = 100 μm. (B) The autophagy levels of HTR cells exposed to TiO2 NPs were examined by immunofluorescence; the nuclei were stained blued with DAPI and the autophagosomes were stained red with CY3. Their fluorescence density was measured with the Zeiss software (https://www.zeiss.com/microscopy/en/products/software/zeiss-zen.html accessed on 9 May 2024) within the laser confocal microscope software package. Scale bar = 20,000 nm. *** p < 0.001, ** p < 0.01. The autophagsomes are indicated by the white circles in the image.
Figure 7. (A) The cellular migration and invasion ability of trophoblastic cell lines (HTR) were determined by a transwell assay; cell counting was obtained from five independent fields of the light microscope, and the data were presented as mean ± SD, scale bar = 100 μm. (B) The autophagy levels of HTR cells exposed to TiO2 NPs were examined by immunofluorescence; the nuclei were stained blued with DAPI and the autophagosomes were stained red with CY3. Their fluorescence density was measured with the Zeiss software (https://www.zeiss.com/microscopy/en/products/software/zeiss-zen.html accessed on 9 May 2024) within the laser confocal microscope software package. Scale bar = 20,000 nm. *** p < 0.001, ** p < 0.01. The autophagsomes are indicated by the white circles in the image.
Toxics 12 00367 g007
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Li, H.; Miao, D.; Hu, H.; Xue, P.; Zhou, K.; Mao, Z. Titanium Dioxide Nanoparticles Induce Maternal Preeclampsia-like Syndrome and Adverse Birth Outcomes via Disrupting Placental Function in SD Rats. Toxics 2024, 12, 367. https://doi.org/10.3390/toxics12050367

AMA Style

Li H, Miao D, Hu H, Xue P, Zhou K, Mao Z. Titanium Dioxide Nanoparticles Induce Maternal Preeclampsia-like Syndrome and Adverse Birth Outcomes via Disrupting Placental Function in SD Rats. Toxics. 2024; 12(5):367. https://doi.org/10.3390/toxics12050367

Chicago/Turabian Style

Li, Haixin, Dandan Miao, Haiting Hu, Pingping Xue, Kun Zhou, and Zhilei Mao. 2024. "Titanium Dioxide Nanoparticles Induce Maternal Preeclampsia-like Syndrome and Adverse Birth Outcomes via Disrupting Placental Function in SD Rats" Toxics 12, no. 5: 367. https://doi.org/10.3390/toxics12050367

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop